Skip to main content

Latest News

Ellorarxine enters human trials and shows promise for MND sufferers

Key Highlights: Ellorarxine, a novel drug compound developed by Nevrargenics, has demonstrated antioxidant and anti-inflammatory effects, which make it a promising new therapy for treating ALS. The results showed that Ellorarxine increases MAP2 expression at low concentrations, induces neurite outgrowth, ameliorates neuroinflammation and modifies GluA2 expression. Nevrargenics is now proceeding to human trials with Ellorarxine, after receiving the green light from the MHRA.
A computer monitor displaying brain data in fMRI control room.

Defining an ageing-related pathology, disease or syndrome: International Consensus Statement

Around the world, individuals are living longer, but an increased average lifespan does not always equate to an increased health span. With advancing age, the increased prevalence of ageing-related diseases can have a significant impact on health status, functional capacity and quality of life.
An elderly lady's hands

Celebrating five years of applied research collaboration across the North East and North Cumbria

This week, the 15 NIHR Applied Research Collaborations (ARCs) in England celebrate their fifth birthday – marking five years of working together regionally and nationally, to develop and deliver applied health and care research that tackles some of our most pressing needs.
Young boy in garden with woman holding a giant cabbage

TARPγ8 may be a key molecular biomarker and therapeutic target for brain aging and age-related brain disease

Aging-related decline in memory and synaptic function are associated with the dysregulation of calcium homeostasis, attributed to the overexpression of voltage-gated calcium channels (VGCC).
TARPγ8

Grand Opening of Jubilee Courtyard Garden at Queen Elizabeth Hospital

A new outdoor sanctuary for patients and visitors has opened at the Queen Elizabeth Hospital Gateshead. The “Garden of Hope” in the Jubilee Wing courtyard has been created with support of Gateshead Health Charity.
Lord-Lieutenant of Tyne and Wear Ms Lucy Winskell OBE cutting the ribbon with Alison Marshall, chair of Gateshead Health

Honorary Fellow Thorston Fogen's latest publication: Doctors and Patients in Martial's Epigrams

This article examines Martial’s epigrams dealing with medical practitioners and their various interactions with others, especially with their patients.

WRIHW Success at the World Association for Photobiomodulation Therapy

PBM2024 was the largest WALT (World Association for Photobiomodulation Therapy) international conference in its 30-year history, and featured renowned speakers from around the globe, representing the latest advancements in Photobiomodulation research.
Paul Chazot at PBM

WRIHW Newsletter 135 is out now!

The latest Wolfson Research Institute for Health and Wellbeing Newsletter should have arrived in your inbox this morning!
Wolfson Research Institute sign

‘Fantastic’ Live Well with Pain highlighted on Radio 4’s Today programme

TV and radio presenter Kirsty Young has spoken out about her ongoing struggle with chronic pain, on Radio 4’s Today programme.
Live Well With Pain High Five

Wolfson ECR Mohi Ziyachi recieves award

Mohi Ziyachi, WRIHW ECR Committee member and NENC ARC Fellow based in Sociology has recently been awarded a Renkei mobility grant
Mohi Ziyachi

Multiple concussions in rugby players change proteins in their blood

A new study shows that retired rugby players who have suffered multiple concussions have abnormal levels of certain proteins in their blood.
St Marys student playing rugby

Red near infrared light therapy in Motor neurone disease (MND)

We're thrilled to share the incredible journey of Seb Bousie, who was diagnosed for motor neuron disease 8 years ago.. Seb has been using the CERA Thrive PBMT System for 6 months, and in combination with a healthy diet and a supplement regimen, he has experienced a remarkable transformation in his health.
Seb Bousie